⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6437040 | 0.63 | — | — | |
| Hydrochloric Acid SCHEMBL6437946 | 0.63 | — | — | |
| SCHEMBL8913 | 0.59 | — | — | |
| SCHEMBL503396 | 0.59 | — | — | |
| SCHEMBL6223 | 0.59 | — | — | |
| SCHEMBL8679785 | 0.59 | ALDH1A1 (1.00) | — | |
| SCHEMBL14861 | 0.59 | TDP1 (1.00) | — | |
| Hydrochloric Acid SCHEMBL25381110 | 0.56 | TSHR (0.89) | — | |
| SCHEMBL2036697 | 0.56 | — | — | |
| SCHEMBL775104 | 0.56 | ALDH1A1 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 449 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1995013270-A1 | NOVEL TAXICINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | RHONE-POULENC RORER S.A. (FR) | 1995-05-18 | — | — | WO | claimed |
| EP-0531382-A1 | N-SUBSTITUTED-1,2,4-TRIAZOLONE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1993-03-17 | — | — | EP | claimed |
| WO-1992015317-A1 | SYNTHETIC PREPARATION OF AMYLIN AND AMYLIN ANALOGUES | AMYLIN PHARMACEUTICALS, INC. (US) | 1992-09-17 | — | — | WO | claimed |
| EP-0410182-A2 | A new technique for rapid peptide coupling | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1991-01-30 | — | — | EP | claimed |
| EP-0383686-A1 | 2-Amino-7-hydroxytetraline carboxyalkyl ethers | ELF SANOFI (FR) | 1990-08-22 | — | — | EP | claimed |
| EP-0049448-B1 | BETA-LACTAM ANTIBIOTICS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM | BAYER AG (DE) | 1988-08-24 | — | — | EP | claimed |
| EP-0050856-B1 | NEW PEPTIDE, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING IT | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-12-27 | — | — | EP | claimed |
| EP-0002774-B1 | PROCESS FOR ACYLATING 7AMINOCEPHEM DERIVATIVES | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-09-23 | — | — | EP | claimed |
| JP-1299298-A | — | — | None | — | — | JP | disclosed |
| CN-122036557-A | Cycloserine intermediate and application thereof | 山东潍坊润丰化工股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | disclosed |
| EP-4373811-A1 | NOVEL 1,2-DIAMINOBENZIMIDAZOLE DERIVATIVE | Carna Biosciences, Inc. (JP) | 2024-05-29 | — | — | EP | disclosed |
| EP-4337203-A1 | INHIBITORS OF THE MENIN-MLL INTERACTION | Syndax Pharmaceuticals, Inc. (US) | 2024-03-20 | — | — | EP | disclosed |
| US-11873307-B2 | Manufacture of compounds and compositions for inhibiting the activity of SHP2 | NOVARTIS AG (CH) | 2024-01-16 | — | — | US | disclosed |
| EP-0003456-B1 | 3-AMINO-CARDENOLIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND MEDICINES CONTAINING THEM | ETABLISSEMENTS NATIVELLE S.A. (FR) | 1984-11-07 | — | — | EP | disclosed |
| EP-0117797-A1 | Nitroso ureas, process for their preparation and their therapeutic use | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1984-09-05 | — | — | EP | disclosed |
| US-4453003-A | ENZYME INHIBITORS, ANTIINFLAMMATORY AGENTS | UMEZAWA HAMAO (JP) | 1984-06-05 | — | — | US | disclosed |
| EP-0050856-A2 | New peptide, process for its preparation and pharmaceutical composition containing it | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1982-05-05 | — | — | EP | disclosed |
| US-4189604-A | PEPTIDASE ENZYME INHIBITORS | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) | 1980-02-19 | — | — | US | disclosed |
| US-4060688-A | Cephalosporin intermediates | ELI LILLY AND COMPANY (US) | 1977-11-29 | — | — | US | disclosed |